Starpharma Holdings Limited (SPHRF)
Develops dendrimer technology for vaginal gels, antivirals, and cancer drug delivery systems.
$0.35-0.36%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+733.3%
The outlook
SPHRF is trading near the middle of its 52-week range with a neutral outlook from analysts. The stock sits between its short and long-term moving averages, showing no clear directional momentum. Today's price action is flat.
What’s behind the score
Price trendMixed vs its moving averages
52-week range56% of the way from its 52-week low to high
Market cap
$147.3M
52-wk high
$0.58
52-wk low
$0.06
50-day avg
$0.50
200-day avg
$0.34
Trailing P/E
—